NuCana plc ( NCNA) - Key Metrics
NCNA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.74 | -$0.46 | -$0.46 |
| 2026Q1 | $0 | -$1.05 | -$0.86 | -$0.88 |
| 2025Q4 | $0 | -$0.67 | -$0.31 | -$0.32 |
| 2025Q3 | $0 | -$0.08 | $0.35 | $0.33 |
| 2025Q2 | $0 | -$5.15 | -$0.96 | -$0.97 |
NCNA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.38 |
| 2026Q1 | 0% | -0.25 |
| 2025Q4 | 0% | -1.01 |
| 2025Q3 | 0% | -11.50 |
| 2025Q2 | 0% | -0.40 |
NCNA
Price: $1.14
52 week price:
Earnings Per Share: 65.09 USD
P/E Ratio: 0.02
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 46300
Market Capitalization: 6.9 million